•  
  •  
  •  
  •  

2026-07-20 04:15:21

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million

Keywords Selected:  USFDA

Stock Report

  • Alembic Pharmaceuticals Limited's Partner NATCO Pharma Limited receives USFDA Tentative Approval for Olaparib Tablets, 100 mg and 150 mg
  • NATCO receives Tentative Approval for Olaparib Tablets from the U.S. FDA
  • USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, USA
  • Ajanta Pharma Ltd receives EIR from USFDA for Paithan facility
  • Lupin Receives EIR from U.S. FDA for its Somerset Facility with VAI Classification
  • US FDA inspection at Glenmark Pharmaceuticals Ltd's manufacturing facility in Goa, India
  • Completion of US FDA Inspection at Auroactive Pharma Pvt Ltd
  • Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dapsone Gel, 5%
  • Lupin receives Tentative Approval from U.S. FDA for Enzalutamide Tablets
  • Completion of US FDA Pre-Approval Inspection at Eugia Steriles Private Limited
  • Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Binimetinib Tablets, 45 mg
  • Classification of US FDA Inspection at Unit-III of Eugia Pharma Specialities Ltd, Pashamylaram as OAI
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Tretinoin Cream USP, 0.05%
  • USFDA inspection at Cipla Ltd's manufacturing facility in Verna, Goa, India
  • Alembic Pharmaceuticals Ltd announces USFDA Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg
  • Concord Biotech Ltd receives ANDA approval for Tofacitinib Tablets, 5 mg and 10 mg
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg
  • Lupin receives approval from U.S. FDA for Ranluspec™ (ranibizumab) Injection
  • Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg
  • NATCO and Lupin receive approval from U.S. FDA for Eribulin Mesylate Injection
  • Concord Biotech Ltd receives ANDA approval from USFDA for Mycophenolate Mofetil for Oral Suspension USP
  • Zydus Therapeutics receives USFDA priority review to NDA for Saroglitazar
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Levothyroxine Sodium Tablets USP
  • Lupin Receives U.S. FDA Approval for Famotidine Injection, USP

Latest Post

  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025